Neurovascular coupling in patients with relapsing-remitting multiple sclerosis

被引:8
|
作者
Uzuner, Gulnur Tekgol [1 ]
Uzuner, Nevzat [1 ]
机构
[1] Eskisehir Osmangazi Univ, Fac Med, Dept Neurol, TR-26480 Meselik, Eskisehir, Turkey
关键词
Multiple sclerosis; Relapsing-remitting; Transcranial Doppler; Neurovascular coupling; Blood flow velocity; BLOOD-FLOW RESPONSE; TRANSCRANIAL DOPPLER; CEREBROVASCULAR REACTIVITY; DIAGNOSTIC-CRITERIA; STIMULATION; GUIDELINES;
D O I
10.1016/j.clineuro.2016.04.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Also to the inflammatory demyelinating lesions and degenerative process, altered cerebrovascular reactivity or neurovascular coupling (NVC) might be considered as playing another role in the pathogenesis of multiple sclerosis. The objective of this study is to assess the NVC of patients with relapsing-remitting multiple sclerosis (RRMS) during the acute exacerbation period. Patients and methods: Four hundred fifty-eight patients with RRMS and 160 healthy subjects were screened for this study during the last 14 years. We performed transtemporal transcranial Doppler recordings from the P2-segments of both posterior cerebral arteries simultaneously during simple or complex visual stimulation. The NVC was defined as a relative increase of the blood flow velocities as a percentage change of the baseline values during visual stimulation. Results: The NVC to simple visual stimulation was significantly higher in the patients on both sides (37.2 +/- 13.5% and 36.0 +/- 14.8%; right and left side, respectively) from those of the controls (30.9 +/- 9.9% and 30.0 +/- 8.8%; right and left side, respectively) (p < 0.01). Similarly, the NVC to complex visual stimulation was significantly higher in the patients (43.3 +/- 14.1% and 41.7 +/- 13.5%; right and left side, respectively) from those of the controls (38.6 +/- 14.2% and 37.6 +/- 14.1%; right and left side, respectively) (p<0.05). Conclusion: Our results suggest that patients with RRMS during exacerbation period have more reactive neurovascular units in the occipital cortex. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 28
页数:5
相关论文
共 50 条
  • [1] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [2] Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
    Nocentini, U
    Pasqualetti, P
    Bonavita, S
    Buccafusca, M
    De Caro, MF
    Farina, D
    Girlanda, P
    Le Pira, F
    Lugaresi, A
    Quattrone, A
    Reggio, A
    Salemi, G
    Savettieri, G
    Tedeschi, G
    Trojano, M
    Valentino, P
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2006, 12 (01): : 77 - 87
  • [3] Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis
    Chan, Andrew
    de Seze, Jerome
    Comabella, Manuel
    CNS DRUGS, 2016, 30 (01) : 41 - 51
  • [4] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [5] Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset
    Koch, Marcus W.
    Moral, Ester
    Brieva, Luis
    Mostert, Jop
    Strijbis, Eva M. M.
    Comtois, Jacynthe
    Repovic, Pavle
    Bowen, James D.
    Wolinsky, Jerry S.
    Lublin, Fred D.
    Cutter, Gary
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (14) : 1776 - 1785
  • [6] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [7] Postural Control in Relapsing-Remitting Multiple Sclerosis
    Cusin, Flavia Salvaterra
    Tomaz, Andreza
    Gananca, Mauricio Malavasi
    Oliveira, Enedina Maria
    Falcao Goncalves, Alessandra Billi
    Caovilla, Heloisa Helena
    INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2022, 26 (04) : 592 - 604
  • [8] Current management of relapsing-remitting multiple sclerosis
    Sedal, L.
    Wilson, I. B.
    McDonald, E. A.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (10) : 950 - 957
  • [9] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
    Miller, Aaron E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
  • [10] Mycophenolate mofetil for relapsing-remitting multiple sclerosis
    Xiao, Yousheng
    Huang, Jianyi
    Luo, Hongye
    Wang, Jin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):